Inhibrx Biosciences, Inc. (INBX) › RevenueInhibrx Biosciences, Inc. (INBX) — RevenueAnnual figures by fiscal year, from SEC filings.2023: $1.80M2024: $200.0K2025: $1.30M$1.30M2023Revenue (USD)2025Fiscal YearRevenueChange YoY2025$1.30M+550.0%2024$200.0K-88.9%2023$1.80M—Other metrics: Cost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share